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Abstract 
A series of palladium(II) halo complexes of the types 
[PdX2L2].nH2O {n = 0, X = Cl, L = L2, L4 and L5; X = Br, L = 
L2; n = 1, X = Cl, L = L1 and L3} and Pd2X4L3 [X = Br, L = 
L1, L3, L4  and L5] were prepared where L is 6-R-5,6-
dihydrobenzoimidazo quinazoline (R-Diq; where R = 
ethyl: L1/ n or i-propyl: L2, L3/ n or i-butyl: L4, L5) and 
characterized by elemental analyses, conductivity 
measurements, TGA, infrared, electronic, NMR and mass 
spectral techniques. Based on these studies 
monomeric/dimeric structure with a square planar 
geometry around the metal ion was proposed for all the 
complexes. Some of the complexes were investigated for 
anti-microbial activity. 
Keywords: dihydrobenzoimidazoquinazoline, palladium(II), 
spectroscopy, thermal analysis, mass spectra. 
1. Introduction 
N-heterocycles like imidazoles, benzimidazoles and quinazolines 
have the ability to stabilize various oxidation states of metals 
belonging to the first and second row transition series.  
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Quinazolines are an important class of N-heterocycles and are 
widely recognized for their medicinal applications. The quinazoline 
moiety is an important part of many natural alkaloids [1] and some 
natural substituted quinazolines exhibit intrinsic hypertensive, 
diuretic and uterotonic properties [2]. They also exhibit various 
biological activities like antiallergenic, antibacterial and 
antihelminthic [3]. Some of the compounds have been evaluated as 
cellular mitosis inhibitors [4], [5].These compounds are found to be 
useful in  several areas like anticorrosion agents, as optical 
materials and as fluorescent tags in DNA sequencing [6-9]. 
Palladium(II) being a d8 metal ion usually exhibits square planar 
geometry but reports of trigonal bipyramidal geometry are also 
available.  
Complexes of divalent palladium find applications in catalysis [10], 
[11], biochemical reactions [12], environmental  studies [13] and as 
anticancer drugs [14]. In view of the importance of quinazoline 
derivatives and palladium complexes, a series of such complexes 




















































All the reagents were of analar grade. The solvents used were 
purified according to standard procedure. Palladium chloride was 
obtained from Arora Matthey, Kolkata, India. Palladium bromide 
and N-heterocycles were prepared according to the published 
procedures [15] – [18].  
Microanalyses were obtained from 240B Perkin – Elmer elemental 
analyzer. IR (nujol mull) spectra were recorded on Shimadzu FTIR 
8400s spectrometer and far-IR spectra were recorded on a Bruker 
IFS 66 v/S instrument. Electronic spectra of complexes in DMF 
were recorded on Shimadzu UV 3101PC spectrophotometer. FAB 
mass spectra were recorded on a JEOL SX102 Mass Spectrometer at 
room temperature using Argon/Xenon as the FAB gas and                       
m-nitrobenzyl alcohol as the matrix and ESI-MS was recorded 
using Micromass Quattro II triple quadrupole mass spectrometer. 
NMR spectra of the compounds in DMSO-d6 were recorded on a 
Bruker WH 270 MHz and Bruker AMX 400 MHz spectrometers 
(both equipped with Aspect 2000 computers). Molar conductivity 
measurements were made on a Systronic conductivity meter 304 - 
cell type CD-10.  
2.1 Synthesis 
2.1.1 6-R-5,6-dihydrobenzoimidazo[1,2-c]quinazoline derivatives 
(L1, L3 - L5) 
Synthesis and characterisation of L2 was reported earlier [17].                    
6-R-5,6-dihydrobenzimidazo[1,2-c]quinazoline derivatives (L1, L3 - 
L5) were synthesized as follows. A mixture of 2-aminophenylbenz 
imidazole (0.05 mol) in 200 ml alcohol and the corresponding 
aldehyde (0.05 mol; L1, propionaldehyde/ L3, i-butyraldehyde/ L4, 
n-valeraldehyde or L5, i-valeraldehyde) was refluxed for 5 hours. 
The resulting solution was concentrated under reduced pressure to 
a small volume to obtain a yellow compound. It was filtered and 
recrystallised from alcohol to get cream/white crystalline 
compound. Yield: 60 -70%.  




2.1.2 [PdX2L2]∙H2O & Pd2X4L3 
Palladium halide (chloride and bromide) was reacted with 
quinazoline derivatives L1 to L5 in acetone in 1:1 mole ratio to 
produce complexes of the types [PdX2L2]∙H2O {n = 0, X = Cl, L = L2, 
L4, L5, X = Br, L = L2 and L4; n = 1, X = Cl, L = L1 and L3} and 
Pd2X4L3 [X = Br, L = L1, L3 and L5]. These complexes were filtered, 
washed with acetone, water and dried in vacuum. Yield 65%. 
3. Results and Discussion 
The complexes were partially soluble in common organic solvents 
but completely soluble in DMF and DMSO in which they behaved 
as non-electrolytes. The analytical and physical data of the 
complexes are given in Table 1.  The infrared spectra of the 
complexes exhibited peaks similar to those of the uncoordinated N-
heterocycles L1 to L5 except for minor shifts implying the 
coordination of the ligands to palladium(II) ion [19], [20]. The 
spectra of I and V exhibited peaks at 3476 and 3452 cm-1 
respectively assignable to υO-H of lattice water. Spectra of L1 to L5 
revealed υC=N of benzimidazole and υC=C of benzimidazole and 
quinazoline moieties in the region 1616 – 1618 cm-1 and these 
complexes were shifted by 2 - 6 cm-1 on complexation. The spectra 
of these complexes  I to X exhibited υN-H in-plane bending vibration 
around 1581 cm-1 and υC-N and δNH in the region 1331 – 1342 cm-1. A 
peak due to CH out-of-plane deformation of quinazoline ring 
vibration was observed in the range 1157 – 1161 cm-1. CH out-of-
plane bending vibrations exhibited a peak in the range 850 - 858 
cm-1. Skeletal vibrational frequency of quinazoline moiety was 
observed in the region 655 – 670 cm-1. The far-IR spectra of the 
complexes revealed the presence of Pd – X (Cl or Br) bond in the 
complexes. The spectra of the chloro complexes of L1 – L5 had a 
strong peak in the range 330 – 334 cm-1 assignable to the terminal 
υPd-Cl [21] and bromo complexes had exhibited a forked peak in the 
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#: Ω-1cm2mol-1, in DMF; *: calculated values are in parentheses. 
The electronic spectra of the complexes I to X were recorded in 
DMF and compared with those of L1 to L5.  The complexes 
displayed bands at 29,990 and 34,060 cm-1 assignable to π – π* and 
n – π* transitions respectively of the N-heterocycles. The band due  
to metal-to-ligand charge-transfer transition dπ → pπ* was 
observed in the region 27,000 to 27,700 cm-1 and  d-d transition 
appeared as weak band in the range 20,200 to 22,300 cm-1 
assignable to 1B1g → 1A1g transition which is characteristic of a 
palladium(II) square planar complex [22] – [25]. The electronic and 
far-IR spectral data are compiled in Table 2.  
The 1H and 13C NMR spectroscopic assignments of the complexes 
of L1 – L5 were made based on the 2D spectral studies and reported 



















C             H             N 
I Pale yellow PdCl2C32H32N6O 






II Dark yellow Pd2Br4C48H45N9 






III Yellow PdCl2C34H34N6 






IV Dark yellow PdBr2C34H34N6 






V Yellow PdCl2C34H36N6O 






VI Dark yellow Pd2Br4C51H51N9 






VII Dark yellow PdCl2C36H38N6 






VIII Pale yellow PdBr2C36H38N6 






IX Yellow PdCl2C36H38N6 






X Dark yellow Pd2Br4C54H57N9 











spectra exhibited both positive and negative coordination induced 
shifts (c.i.s.) attributed to ligand–to–metal σ–donation and metal-to-
ligand π–back donation [28]. 


















*: spectra recorded in DMF; values in paranthesis are molar extinction coefficients 
The proton NMR spectral data of the complexes of L1 to L5 were 
comparable with those of the uncoordinated N-heterocycles (Table 
3). The spectra of the ligands exhibited a singlet around 7 δ due to 
the NH proton of quinazoline moiety while in the spectra of the 







X = Cl /Br 
Ligand transitions MLCT d-d 
transition 
n → π*  &  π → π* dπ → pπ* 1B1g → 1A1g 
I 334 33990(18294), 
32895(19072) 
27100(1036) 22104(155) 
II 249,264 34060(18858), 
33025(21395) 
27640(11606) 20358(134) 
III 333 34037(16383), 
32984(17837) 
27472(9149) 22026(328) 
IV 271,282 33921(10516), 
32906(10892) 
27144(4366) 22222(342) 
V 331 33990(21908), 
32916(23496) 
26998(3067) 22056(148) 
VI 244,261 33990(18242), 
33003(21899) 
27579(1819) 20284(216) 
VII 332 33967(20844), 
29916(27100) 
27100(2695) 22017(83) 
VIII 259,274 33990(20274), 
32982(21888) 
27397(2018) 20973(233) 
IX 330 33967(9934), 
32895(10415) 
27129(6126) 22272(90) 
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3.74 δ. CH proton resonance which was observed as a singlet 
around 6δ in the spectra of the heterocycles exhibited a shift by 
about 0.38 on complexation. In complexes I to X protons resonances 
of the quinazoline moiety H – 7, 8, 9, and 10 appeared in the region 
8.68 – 6.77 δ with positive and negative c.i.s. of -0.02 – 1.17 δ. The 
signals of benzimidazole ring protons H – 2′, 3′, 4′ and 5′ appeared 
as multiplets between 8.04 and 7.46 δ and were shifted by about -
0.27 to 0.64 δ in the complexes. The alkyl proton peaks of the 
ligands were seen in the upfield region between 1.86 and 0.75 δ as a 
triplet for the CH3 group and as multiplets for the CH2 and CH 
groups with c.i.s. values in the range -0.78 – 0.26 δ. 
The 13C NMR spectra of L1 – L5 and those of palladium(II) 
complexes exhibit similar patterns barring minor shifts in the 
positions of the signals on complexation. The resonance signal of     
C-2 for the ligands was observed to be shifted to the downfield 
region of 147.16 – 143.95 δ as it is bonded to two nitrogen atoms 
and carbon atom and hence most deshielded. Negative shift in the 
range -C-6′ and C-7′ which are also bonded to one nitrogen 
appeared in the downfield region 134.80 – 131.70 δ and 144.79 – 
140.32 δ respectively. Of the two, the resonance of C-7′ was shifted 
more downfield by ~ 11 δ as compared to C-6′ as it is bonded to 
tertiary nitrogen. The quinazoline carbons C - 3, 7, 8, 9 and 10 
exhibited resonance signals in the range δ 133.59 - 110.36 and were 
shifted upfield by 3.05 to 7.24 δ on complexation. The 
benzimidazole carbons 2′, 3′, 4′ and 5′ showed signals between 
127.79 - 104.32 δ and these exhibited positive and negative shifts in 
the range -5.15 – 5.07 δ on complexation. The resonance signals of 
the substituted alkyl carbons appeared in the upfield region 43.31 – 
8.56 δ with c.i.s. values of -12.35 to 4.50 δ.  
Thermogravimetric analysis of I and V revealed that both the 
complexes lose a water molecule below 100°C indicating the 
presence of lattice water. The chloride ions were lost below 330°C. 
The loss of heterocycles was observed above 430oC for I and above 
336 °C for II. 
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The electrospray ionization mass spectrum was recorded for 
complex VI. It exhibited a peak at m/z 1322 supporting dimeric 
nature of the complex. The spectrum also exhibited twin peaks 
separated by two mass units at 1058 and 1060 for Pd2Br4L32, at 1054 
and 1056 for PdBr2L33, at 795 and 797 for Pd2Br4L3 and 791 and 793 
for PdBr2L32 due to the isotopes of bromine, 79Br and 81Br of natural 
abundances of 50.5 and 49.5 respectively. Decomposition pattern of 
Pd2Br4L33 (VI) is depicted in Scheme 1. 
 
Pd2Br3L33(1240)     -Br, -2H     Pd2Br4L33 (VI)   -2L        Pd2Br4L3(795,797)               
                                                   (m/z 1322)                                    
    -L                         -2Br                           -PdBr    
  Pd2Br3L32(976)       Pd2BrL33(1162)        PdBr3L33(1135)   -Br       PdBr2L33(1056, 1054) 
 
           - PdBr2              -Pd                         -L                                                                  
                                                                                                                               
               PdBrL32(793, 791)                        L(264)                         
                                                   -PdBrL                                          -2PdBr2                                                                             
Scheme 1: Decomposition pattern of Pd2Br4L33 (VI) 
4. Stereochemistry 
 Coordination of the N-heterocycles to the metal ion is indicated by 
the analytical data, molar conductance, IR and 1H and 13C NMR 
spectral results. The electronic spectral results imply the presence 
of a square planar geometry around the palladium(II) ion. The 
thermogram of the chloro complexes of L1 and L3 suggest the 
presence of lattice water. The far-IR spectra reveal the presence of 
terminal halides for all the complexes. FAB-MS of the complex 
[Pd2Br4(L3)3] supports binuclear structure for the complex. The N-
heterocycles behave as monodentate ligands coordinating through 
the tertiary nitrogen of the benzimidazole moiety whereas in 
bromo complexes of L1, L3 and L5, they act as both monodentate 
and bridging bidentate coordinating through the tertiary nitrogen 
of the benzimidazole moiety and the nitrogen of the quinazoline 
moiety.  Based on these studies a monomeric structure is proposed 
for the chloro complexes of L1 to L5 and bromo complexes of L2 and 




L4 (Π) and a dimeric structure is assigned for the bromo complexes 
of L1, L3 and L5 (Ш). 
 
PdX2L2 
X = Cl, R = ethyl, n-propyl, i-propyl, n-butyl or i-butyl 
X = Br, R = n-propyl or n-butyl 
Π 
 
Pd2X4L3, X = Br, R = ethyl, i-propyl or i-butyl 
Ш 
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5. Biological Activity 
Two of the quinazoline derivatives L1 and L4 and their chloro 
complexes of Pd(II) were tested for in vitro growth inhibitory 
activity against Bacillus subtilis, E.coli and Yeast by cup - plate 
method [29-32]. Septran and ampicillin was used as the standard 
antibiotics for Bacillus subtilis and E.coli respectively while 
grissoflumin was used as the standard antifungal agent. The 
toxicity of the quinazoline derivatives against the microbes was 
found to be effective at 50 ppm concentration against Bacillus 
subtilis and Yeast and 100 ppm against E.coli (Table 4). The Pd(II) 
complexes were found to be effective against the microbes at 100 
ppm concentration. It was observed that the Pd(II) complexes 
exhibit lower inhibitory activity as compared to those of the 
quinazoline derivatives. Though the metal complexes and 
quinazoline derivatives proved to be toxic against microorganisms, 
the standard drugs were found to be more toxic. The ligand L1 and 
the chloro complex of L4 were found to be ineffective against the 
microbe E.coli and the palladium salt PdCl2 was found to be 
ineffective against the microbe Bacillus subtilis. Both the ligands and 
their complexes were effective against Yeast with the complexes 
showing greater percentage inhibition. 









L1 46 nd 40 I 14 23 63 
L4 57 50 50 VII 50 nd 61 
Standard 76 76 67 PdCl2 nd 75 69 
*: (%inhibition); nd: not detected; ‡: concentration: 50 ppm for Bacillus subtilis , Yeast and 100 ppm 
for E.coli;  †: concentration: 100 ppm. 
6. Conclusion  
Synthesis of chloro and bromo complexes of palladium II with 
dihydrobenzoimidazo quinazoline derivatives L1 – L5 were carried 
out and characterised by various physicochemical techniques. 
Based on these studies monomeric/dimeric structures with square 




planar geometry around the palladium(II) ion have been proposed. 
Two of the heterocycles L1 and L4 and their chloro complexes with 
palladium(II) were tested for antimicrobial activity and found to be 
moderately active. 
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